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Blood Pressure and Cognitive Function in an African-American and a
Caucasian-American Sample: The Maine-Syracuse Study
MICHAEL A. ROBBINS, PHD, MERRILL F. ELIAS, PHD, MPH, PENELOPE K. ELIAS, PHD,
AND MARC M. BUDGE, MBBS, BMEDSC, FRACP
Objective: The primary purpose of this study was to examine associations between indices of blood pressure (BP) and cognitive
function for African-American participants in the Maine-Syracuse Longitudinal Study (MSLS). Corresponding data for the
Caucasian-American MSLS participants were included to provide a basis for comparison. Interactions of age with BP indices were
also assessed in relation to cognitive function. Methods: Data were drawn from the baseline MSLS questionnaires, medical
interviews and examinations, Wechsler Adult Intelligence Scale subtests, and measurements of BP for 1563 participants, of whom
147 were African American. Multiple linear regression analyses were employed to examine the relationship between several BP
predictors and cognitive outcomes with statistical adjustment for demographic, psychosocial, and cardiovascular risk factors.
Results: Significant inverse associations between BP indices and cognitive performance were obtained for both racial cohorts but
were generally of higher magnitude for the African-American cohort. Interactions of BP with age were not obtained for any of the
cognitive test scores. Conclusions: Elevations in BP are associated with poorer cognitive function for African-American and
Caucasian-American cohorts. These associations are similar for younger and older participants. Key words: African American,
blood pressure, hypertension, cognitive function.
BP ⫽ blood pressure; MSLS ⫽ Maine-Syracuse Longitudinal Study;
WAIS ⫽ Wechsler Adult Intelligence Scale; SBP ⫽ systolic blood
pressure; DBP ⫽ diastolic blood pressure.

INTRODUCTION
pproximately 30% of the adult population in the United
States, an estimated sixty-five million people, has arterial
hypertension (1). Hypertension poses an increased risk for
myocardial infarction, congestive heart failure, end-state renal
disease, and stroke (2–5). Recent reviewers conclude that
hypertension is also a risk factor for lowered cognitive functioning, and that functional and structural changes in the
brain that accompany hypertension are a likely basis for this
association (6,7). This research on hypertension and blood
pressure (BP) in relation to cognitive performance has been
conducted primarily with Caucasian samples. Consequently
little information for African Americans is available (8).
Further research on relations between indices of BP level
and cognitive functioning for African Americans is important
because the prevalence and incidence of hypertension for
African Americans is higher than the levels observed for other
racial groups in the US (1,9,10). Beginning in young adulthood, and continuing across the adult life-span, African Americans have higher BP values than other racial groups (9). This
phenomenon is related to the higher prevalence and incidence
of cardiovascular mortality and morbidity, including vascular
dementia, experienced by African Americans (11–13).
Although the higher prevalence of hypertension among
African Americans emerges in early adulthood, most studies
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of BP and cognitive functioning in African Americans have
included only middle-aged and older subjects and/or limited
cognitive test batteries (8,14 –17), and results have been
mixed.
In one study with an African-American sample (age range
43– 82 years), investigators reported relations between only
one of six neuropsychological tests and either systolic BP
(SBP) or diastolic BP (DBP) (8). Counter to expectations
based on the literature (6,7), higher DBP was related to better
performance on the Digits Forward test.
Other investigations have reported comparative data for
African-American participants in large multi-racial samples
(14 –17), although for limited cognitive test batteries. The
Short Portable Mental Status Questionnaire, a 10 item screening instrument for cognitive functioning, was used to examine
cognitive change over a 3 year period in relation to measured
BP for one large sample of African Americans and Caucasian
Americans (age 65 or over at baseline) (14). Curvilinear
associations were obtained such that SBP values in the intermediate range were associated with better performance, and
both low and high SBP values were associated with poorer
performance. This pattern was obtained for both racial samples, but the relationship was statistically significant only for
the Caucasian Americans. Four cognitive measures were used
in another investigation for which the large biracial sample
comprised participants age 65 or older (16) Both high and low
SBP and DBP were associated with poorer performance on
each of the four cognitive measures when compared with
intermediate BP levels. The majority of participants (61.8%)
were African American and results were not affected by
statistical adjustment for race.
Knopman et al. (15) used three cognitive tests to examine
6-year change in performance in relation to BP for a large
biracial sample age 47 to 70 years at baseline (15). They found
that the higher the BP, the greater the decline on the test of
psychomotor speed, although this relationship was nonsignificant within the African-American cohort. Finally, three
cognitive tests were used in a recent study with a large
multi-racial sample that included younger and middle-aged
participants (age 20 –59 years) (17). One linear result, relating
707
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higher BP to poorer performance on serial digit learning was
obtained. A race/ethnicity variable, formed by combining African American and other minority groups for comparison
with nonHispanic Caucasian Americans, did not moderate this
association. However, age cohort did moderate this association (i.e., relations between BP and cognitive performance
were found only for 20 –39 year-old participants and not for
the participants who were 40 –59 years of age).
In summary, findings are equivocal with respect to associations between BP and cognitive functioning for African
Americans, the range of cognitive domains assessed has been
fairly narrow, and we are aware of only one study that included younger participants and reported a multiplicative relation between BP and age (17).
The importance of examining the possibility that age moderates the relationship between BP and cognitive performance
has been clearly established. One major review of the literature from a life span perspective has concluded that although
inverse associations between BP and cognitive function are
found among adults of all ages, there is conflicting evidence
with respect to whether these associations are stronger for
particular age cohorts (18).
Most cross-sectional studies have reported stronger associations for BP and cognitive performance for their younger or
middle-aged cohorts relative to their middle-aged or older
cohorts (17,19 –21). One early longitudinal study with participants conducted 60 years ago found BP relations to cognitive
decline to be stronger for its older cohort (22), and our most
recent longitudinal study (23) found that BP-related decline in
cognitive performance was the same for younger (age 18 to 46
years) and older (age 47 to 83 years) groups. Although findings have been inconsistent, it has been hypothesized that the
physiological mechanisms underlying associations between
BP and cognitive functioning may differ for younger and older
cohorts (6,18). For younger cohorts the underlying mechanisms are more likely to be BP effects on neurophysiological
function (e.g., cerebral blood flow, cerebral metabolism, autoregulation), or sympathetic nervous system or neuroendocrine arousal. For older cohorts the underlying mechanisms
may involve structural change, such as atherosclerosis, atrophy, or white matter disease (6,18).
Because the physiological concomitants of higher BP are
similar for African Americans and Caucasian Americans (9)
our working hypotheses were that (a) inverse linear associations between BP variables and cognitive performance level
would be obtained for both racial groups; (b) the pattern of
relations between BP and specific cognitive abilities would be
similar; and (c) if age cohort differences emerged in associations between BP and cognitive functioning, these associations would be stronger for younger participants.
METHODS
Participants
The study samples compared were composed of community-dwelling
nonHispanic African-American and Caucasian-American residents of upstate
New York who participated in the Maine/Syracuse Longitudinal Study
708

(MSLS) between 1976 and 2002 (23,24). The MSLS was approved by the
Institutional Review Boards at SUNY Upstate Medical University and the
University of Maine. Initial criteria for exclusion from the MSLS include treatment for alcoholism or drug abuse, or a psychiatric history (23). From
the initial pool of 1945 African-American and Caucasian-American subjects,
additional exclusions were made for this study. Because all African-American
subjects were under the age of 80, Caucasian-American subjects age 80 and
above (n ⫽ 46) were excluded to make the age ranges equivalent. Other bases
for exclusion were (a) secondary hypertension (n ⫽ 32) (24); (b) difficulties
in speaking and reading English (n ⫽ 6); (c) an extreme SBP value of 300
mm Hg (n ⫽ 1); (c) missing data for one or more covariates (primarily
depression scale scores, n ⫽ 66; trait anxiety scores, n ⫽ 73; or body mass
indices, n ⫽ 124) used in the expanded regression models described below.
Inclusion of these participants in the sample did not alter the results. Of the
1661 subjects remaining, those with the following health conditions were
excluded in order to reduce the extent of comorbid illness in the sample: (a)
confirmed cerebrovascular disease, including clinical stroke (n ⫽ 23); (b)
confirmed cardiovascular disease (n ⫽ 43); (c) kidney disease (n ⫽ 5); and (d)
other major disease, such as cancer (n ⫽ 27). Inclusion of these individuals
with comorbid illness in the sample did not alter the results for analyses
conducted with the remaining 1563 participants, of whom 147 were African
Americans.

Procedure
Blood pressure data were obtained as a part of studies of the endocrine
bases of hypertension conducted in conjunction with the cognitive studies
(24). With Institutional Review Board approval, participants were asked to
withdraw from their antihypertensive medications from 3 to 21 days before
testing with the permission and under the direction of their personal physician
and with careful supervision by the study physician. Withdrawal from medication was an aspect of the endocrine diagnostic protocol for the medical
studies conducted in parallel and in collaboration with cognitive data collection. Whether participants were withdrawn from medication at all, as well as
the number of days of withdrawal from medication, was determined by the
supervising physicians on an individual basis for each participant. For all
participants, a demographics questionnaire (age, education, occupation), the
Spielberger State-Trait Anxiety Inventory (25), the Zung Depression Scale
(26), the Cornell Medical Index (27), and a scale assessing tobacco and
alcohol use were administered before a medical interview and measurement
of height and weight. Classification of diabetes mellitus was based on the
medical interview and required a history of pharmacological treatment. Blood
pressure was then measured using a Critikon Dinamap 1846SX automated BP
monitor. The optimal cuff size for each individual was used (28). Blood
pressure variables used for analyses were based on the average of 6 sitting, 6
recumbent, and 6 standing BP measurements taken at this test session.
Following BP assessment the tests of cognitive functioning were administered
by a trained psychological examiner.

Design and Data Analysis
Outcome Variables
The dependent (cognitive outcome) variables were the Wechsler Adult
Intelligence Scale (WAIS) tests of Information, Similarities, Digit Span
Forward, Digit Span Backward, Digit Symbol Substitution, and Block Design
(29). Unlike several previous studies of BP and cognitive performance from
our laboratory (e.g., 6,23), not all WAIS subtests were available for this study.
The subtests used were those administered at baseline to all participants
throughout the MSLS. Raw scores for each test were converted to standard (z)
scores so that increments for each score would be expressed in SD units.
These WAIS tests assess a wide variety of cognitive abilities: (a) information
measures retention of general information; (b) similarities measures verbal
concept formation and general mental ability; (c) Digit Span Forward measures attention and immediate memory span; (c) Digit Span Backward measures attention, immediate memory span, and ability to double track; (d) Digit
Symbol Substitution measures attention, visual-motor coordination, and response speed; and (e) Block Design measures spatial perception and organization. These six WAIS scores were summed, and the sum was converted to
Psychosomatic Medicine 67:707–714 (2005)
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a standard (z) score, to produce an index of global cognitive functioning.
Separate multiple regression analyses were conducted for the composite
cognitive test score and for the individual cognitive test scores.

Predictor Variables
The BP predictor variables, SBP (mm兩Hg), DBP (mm兩Hg), and pulse
pressure (mm兩Hg), were entered into separate analyses along with relevant
interactions and covariates.

Covariates
Recent reviewers of this literature have stressed the importance of accounting for demographic variables such as age, education, and gender when
examining associations between BP and cognitive performance (6,7). Consequently we employed multivariable regression models (basic models) that
consisted of one of the BP variables and the following covariates: (a) age (in
years); (b) education (in years); (c) gender (0 ⫽ male, 1 ⫽ female); (d)
occupation (level); and (e) racial cohort (0 ⫽ African American, 1 ⫽ Caucasian American). Occupation was coded on a scale from 1 (unskilled) to 6
(executive/professional). There are additional correlates of BP and cognitive
performance that should be considered for inclusion in statistical models as
covariates (6,7). We chose candidate covariates based on the literature for
examination in preliminary correlation analyses. To be included in the expanded models, each candidate covariate was required to be significantly
correlated with one or more of the BP predictor variables or cognitive
performance variables (p ⬍ .05). In addition to the demographic variables in
the basic model, the expanded model comprised the following: (a) antihypertensive medication use (0 ⫽ no, 1 ⫽ yes); (b) alcohol consumption (drinks per
week); (c) cigarette smoking (number per week); (d) psychotropic medication
use (0 ⫽ no, 1 ⫽ yes); 5) diabetes mellitus (0 ⫽ no, 1 ⫽ yes); (e) body mass
index (kg/m2); (f) trait anxiety scores; and (g) depressive symptom scores.

Tests of Interactions
Interaction terms were calculated as product vectors and entered into each
model in a hierarchical manner after the main effects and covariates (30). The
interaction terms of interest to the study were those that involved age in
conjunction with BP variables and Race. Thus, for example, where SBP was
in the model as a main effect we examined the two-way interactions of SBP
by race, SBP by age, and race by age, as well as the three-way interaction of
SBP by race by age. The statistical test of the two-way interaction terms (i.e.,
SBP by race, SBP by age, and race by age) were controlled for the main
effects of SBP and covariates in the model. The statistical test of the threeway interaction term (i.e., SBP by race by age) was adjusted for all main
effects and the constituent two-way interaction terms. The same approach was
used for DBP and pulse pressure. Alternate analyses were performed in which
age was represented either as a continuous variable or as an age group vector,
with the age groups based on a median split (age 49 years).

RESULTS
Descriptive information for the predictor variables, covariates, and cognitive outcome variables are presented in Table 1.
For both racial samples, occupation levels range from unskilled to executive and professional, and a wide range of age
and education levels are represented. As may be seen in Table
1, in comparison to the Caucasian-American sample, the African-American sample was on average younger and lower in
education and occupation level. African-American participants had higher values for the body mass index, higher scores
on the measure of depressive symptoms, and lower cognitive
test scores. They were less likely to consume alcohol, but were
more likely to smoke cigarettes, be diabetic, and use prescribed psychotropic medications. The only difference with
respect to the BP variables was for DBP, for which AfricanAmerican participants had a higher mean value. The proporPsychosomatic Medicine 67:707–714 (2005)

tion of participants using antihypertensive medication was
equivalent for the two samples.
Hypertensive African Americans (n ⫽ 80) did not differ
from hypertensive Caucasian Americans (n ⫽ 785) with respect to either self-reported duration of hypertension (p ⬎ .80)
or number of days withdrawn from antihypertensive medication before testing (p ⬎ .35). Preliminary analyses were
conducted in which the number of days that hypertensive
participants were withdrawn from medications was examined
as a covariate. This variable was not included in the final
model because it did not show statistically significant associations with any of the cognitive variables and did not affect
the results either for BP variables or for use of antihypertensive medication.
Examination of the correlations among covariates provided
no indication of colinearity (31). The highest Pearson correlations obtained were between Zung Depression Scores
and Trait Anxiety scores (r ⫽ .62 to r ⫽ .66). Correlations
between education and occupation ranged from r ⫽ .41 and
r ⫽ .44. All other correlations were less than r ⫽ .30.
Figure 1 and 2 display scatter plots of Global Composite
scores in relation to SBP for the African-American and Caucasian-American sample, respectively. For display purposes,
in these plots the Global Composite score is expressed as a t
score (z score plus 10). These plots illustrate our findings that
associations in this study are best described by linear functions. Quadratic BP terms and strata of BP values (JNC-7 BP
categories (32) and quintiles of SBP and DBP), were analyzed
separately to determine whether low, as well as high, BP
values were related to cognitive functioning. Lower BP values
were not associated with poorer performance for any of the
WAIS measures.
Major Results
The two- and three-way interaction terms involving age
with BP and/or race were all nonsignificant (p values ⬎ .10).
This was true whether continuous age was used or an age
group vector representing younger and older participants
based on a median split was used. However, significant
two-way interactions of race with SBP and DBP were
obtained for the majority of the cognitive outcome variables (ps ⬍ 0.05).
These interactions are illustrated in Table 2, which shows
results for the regression of WAIS scores on SBP. Regression
coefficients for the African-American and Caucasian-American samples, respectively (first two columns), are adjusted for
the effects of all covariates in the basic model. The corresponding regression coefficients (third and fourth column) are
adjusted for the effects of all covariates in the expanded
model. Regression coefficients presented in bold type indicate
that the SBP by race interaction was significant for that
specific cognitive outcome variable. Importantly, even when
the BP by race interaction was significant, significant inverse
associations between BP and cognitive performance for each
racial sample remained. Results for the Global Composite
measure illustrate this point. With adjustment for the covari709
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TABLE 1.

Characteristics of the Total, African-American, and Caucasian American Samples
Sample

Variable

Systolic BP (mm兩Hg)
Mean
SD
Range
Diastolic BP (mm兩Hg)
Mean
SD
Range
Pulse pressure (mm兩Hg)
Mean
SD
Range
Age (years)
Mean
SD
Range
Education (years)
Mean
SD
Range
Occupation (level)
Mean
SD
Range
Depressive symptoms
Mean
SD
Range
Trait anxiety
Mean
SD
Range
Body mass index (kg/m2)
Mean
SD
Range
Gender (% Female)
Alcohol use (% current)
Smoker (% current)
Antihypertensive medication (%)
Treatment for diabetes (%)
Psychotropic medication use (%)
Global composite (z score)
Mean
SD
Range
Block design
Mean
SD
Range
Digit symbol
Mean
SD
Range
Information
Mean
SD
Range

pa

Overall
(n ⫽ 1563)

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

137.9
27.6
85–272

139.2
29.7
96–260

137.8
27.4
85–272

ns

81.5
18.1
44–160

84.5
20.4
48–160

81.2
17.8
44–146

.05

56.4
16.9
22–161

54.7
15.1
25–113

56.6
17.1
22–161

ns

49.1
15.0
18–79

43.4
10.7
18–76

49.7
15.2
18–79

.001

14.2
2.7
5–20

12.6
2.5
5–20

14.4
2.6
6–20

.001

4.4
1.4
2–6

3.7
1.6
2–6

4.4
1.3
2–6

.001

42.6
9.6
25–84

46.2
10.5
28–84

42.2
9.4
25–84

.001

35.1
9.1
20–74

36.1
9.2
21–71

35.0
9.1
20–74

ns

27.8
5.7
15.8–61.3
56.7
44.2
13.5
37.4
4.1
5.9

30.6
7.2
17.8–61.3
61.2
29.3
23.1
42.2
9.5
10.9

27.6
5.4
15.8–53.0
56.2
45.8
12.5
36.9
3.5
5.4

0.00
1.00
⫺4.87–2.31

⫺1.06
1.14
⫺4.87–1.87

0.10
0.89
⫺3.74–2.31

⬍.001

34.5
8.2
0–48

27.2
9.0
0–46

35.2
7.8
12–48

⬍.001

56.7
12.8
11–90

49.8
13.8
11–90

57.4
12.4
12–90

⬍.001

19.4
5.1
2–29

13.6
6.0
4–27

20.0
4.6
2–29

⬍.001

.001

ns
.01
.001
ns
.01
.01

(Continued)
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TABLE 1. (Continued)
Sample
Variable

Similarities
Mean
SD
Range
Digit span forward
Mean
SD
Range
Digit span backward
Mean
SD
Range
a

pa

Overall
(n ⫽ 1563)

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

17.3
6.9
0–26

14.5
4.8
0–24

17.6
3.9
2–26

⬍.001

6.9
1.3
3–9

6.4
1.2
4–9

6.9
1.2
3–9

⬍.001

5.1
1.4
0–8

4.2
1.5
2–8

5.2
1.4
0–8

⬍.001

Comparison between African-American and Caucasian American samples, t test for means and 2 test for percentages.

Figure 1. SBP in relation to Global Composite t scores (z-score ⫹ 10) for
the African American sample.

Figure 2. SBP in relation to Global Composite t scores (z-score ⫹ 10) for
the Caucasian-American sample.

ates in the basic model, the regression coefficients for the
African Americans and the Caucasian Americans are significant (␤ ⫽ ⫺0.214 and ␤ ⫽ ⫺0.095 respectively, both
p values ⬍ .001). However, the presentation of these regression coefficients in bold type means that the SBP by race
interaction was also significant. The regression coefficient for
the African Americans (␤ ⫽ ⫺0.214) was higher in magnitude
than the regression coefficient for the Caucasian Americans
(␤ ⫽ ⫺0.095).
As also may be seen in Table 2, with adjustment for the
basic covariate model, SBP was inversely associated with
performance on all cognitive measures for Caucasian Americans and with all cognitive measures except for the Digit Span
tests for African Americans. Analyses were undertaken to see
which covariates in the basic model were responsible for
attenuation of crude (unadjusted) regression coefficients between SBP and cognitive performance. Essentially, adjustment for age and education resulted in the greatest attenuation
in these relations. For instance, for the association of the

Global Composite measure with SBP for African Americans,
education and age accounted for the full extent of attenuation
from a crude regression coefficient of ␤ ⫽ ⫺0.330 to the
value of ␤ ⫽ ⫺0.214 shown in Table 2.
A comparison of columns 3 and 4 with columns 1 and 2
shows that, although regression coefficients were further attenuated when adjusted for the additional covariates in the
expanded model, the pattern of inverse associations between
SBP and cognitive performance was essentially the same. The
degree of attenuation in regression coefficients for the expanded, as compared with the basic, model was largely attributable to adjustment for the antihypertensive medication use
covariate. Again using the example of the association of the
Global Composite with SBP for African Americans, adjustment for antihypertensive medication use alone attenuated the
regression coefficient of ␤ ⫽ ⫺0.214 for the basic model to
␤ ⫽ ⫺0.120. Adjustment for all covariates in the expanded
model resulted in the value of ␤ ⫽ ⫺0.114 shown in column
3 of Table 2.

Psychosomatic Medicine 67:707–714 (2005)
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TABLE 2.

Regression Coefficients (␤ ) Expressing Change in Cognitive Performance (in SD units) per 20 mm Hg change in
Systolic Blood Pressure
Basic Modela

Cognitive Test Score

Global composite
Block design
Digit symbol
Information
Similarities
Digit span forward
Digit span backward

␤
sebc
␤
seb
␤
seb
␤
seb
␤
seb
␤
seb
␤
seb

Expanded Modelb

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

ⴚ0.214***
(0.053)
ⴚ0.198***
(0.056)
ⴚ0.204***
(0.046)
ⴚ0.143†
(0.074)
ⴚ0.222***
(0.064)
⫺0.090
(0.058)
0.024
(0.064)

ⴚ0.096***
(0.015)
ⴚ0.026
(0.017)
ⴚ0.115***
(0.016)
ⴚ0.032*
(0.015)
ⴚ0.064***
(0.017)
⫺0.088***
(0.020)
⫺0.046*
(0.020)

ⴚ0.114†
(0.062)
ⴚ0.140*
(0.066)
ⴚ0.150**
(0.056)
ⴚ0.044
(0.070)
ⴚ0.144†
(0.076)
⫺0.042
(0.068)
0.047
(0.073)

ⴚ0.078***
(0.017)
ⴚ0.039*
(0.020)
ⴚ0.082***
(0.018)
ⴚ0.020
(0.018)
ⴚ0.046*
(0.020)
⫺0.089***
(0.024)
⫺0.035
(0.022)

Bold type indicates that the SBP by Race interaction for the cognitive outcome variable was significant (p ⬍ .05) in that model.
p ⬍ .08; * p ⬍ .05; ** p ⬍ .01; *** p ⬍ .001.
a
Basic Model ⫽ SBP, race, age, education, gender, and occupation.
b
Expanded Model ⫽ SBP, race, age, education, gender, occupation, diabetes, body mass index, depressive symptoms, trait anxiety, anti-hypertensive medication,
psychotropic medication, alcohol use, cigarette smoking.
c
seb ⫽ standard error of ␤.
†

Results for DBP, shown in Table 3, largely mirrored the
results for SBP. However, results for pulse pressure diverged
from those for SBP and DBP in that for only one cognitive
test, Digit Symbol Substitution, was there a significant Pulse
Pressure by race interaction (p ⬍ .05). This significant interaction was observed for the basic model and the expanded
TABLE 3.

model. With respect to the basic model, the regression of Digit
Symbol Substitution scores on pulse pressure was significant
for both the African Americans (␤ ⫽ ⫺0.106; seb ⫽ 0.049;
p ⬍ .05) and the Caucasian Americans (␤ ⫽ ⫺0.059; seb ⫽
0.014; p ⬍ .001). Adjustment for the variables in the expanded model attenuated these regression coefficients for both

Regression Coefficients Expressing Change in Cognitive Performance (in SD units) per 10 mm Hg Change
in Diastolic Blood Pressure
Basic Modela

Global composite
Block design
Digit symbol
Information
Similarities
Digit span forward
Digit span backward

␤
sebc
␤
seb
␤
seb
␤
seb
␤
seb
␤
seb
␤
seb

Full Modelb

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

African American
(n ⫽ 147)

Caucasian American
(n ⫽ 1416)

ⴚ0.177***
(0.038)
ⴚ0.155***
(0.040)
ⴚ0.158***
(0.033)
ⴚ0.096*
(0.042)
ⴚ0.167***
(0.046)
⫺0.075†
(0.041)
⫺0.009
(0.047)

ⴚ0.059***
(0.012)
ⴚ0.002
(0.013)
ⴚ0.091***
(0.013)
ⴚ0.011
(0.012)
ⴚ0.040**
(0.014)
⫺0.067***
(0.016)
⫺0.030†
(0.015)

ⴚ0.115*
(0.047)
ⴚ0.110*
(0.049)
ⴚ0.125**
(0.042)
ⴚ0.058
(0.052)
ⴚ0.116*
(0.057)
⫺0.056
(0.051)
0.002
(0.006)

ⴚ0.045***
(0.014)
ⴚ0.002
(0.016)
ⴚ0.065***
(0.015)
0.001
(0.014)
ⴚ0.023
(0.016)
⫺0.070***
(0.019)
⫺0.023
(0.018)

Bold type indicates that the DBP X Race interaction for the cognitive outcome variable was significant (p ⬍ .05) in that model.
p ⬍ .08; * p ⬍ .05; ** p ⬍ .01; *** p ⬍ .001.
a
Basic Model ⫽ Age, Education, Gender, and Occupation.
b
Expanded Model ⫽ SBP, race, age, education, gender, occupation, diabetes, body mass index, depressive symptoms, trait anxiety, anti-hypertensive medication,
psychotropic medication, alcohol use, cigarette smoking.
c
seb ⫽ standard error of ␤.
†
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the African Americans (␤ ⫽ ⫺0.061; seb ⫽ 0.051; p ⬎ .10)
and the Caucasian Americans (␤ ⫽ ⫺0.033; seb ⫽ 0.014;
p ⬍ .05).
Pulse pressure was related to each cognitive variable, with
the exception of Digit Span Backward. These inverse associations between pulse pressure and cognitive performance were
obtained for both the basic and expanded models.
DISCUSSION
Our primary goals for this study were (a) to describe
associations between indices of BP and cognitive functioning
for an African-American cohort; (b) to compare these results
with findings for a Caucasian-American cohort; and (c) to
examine possible age by BP interactions within these cohorts.
With regard to the latter goal, no significant age by BP
interactions were observed. However, as hypothesized, significant inverse linear associations between measures of BP and
cognitive functioning were obtained for both racial cohorts.
These results were observed when relations between BP and
cognitive performance were adjusted for a basic model (age,
education, gender, and occupation) and persisted when adjusted for the expanded covariate model which included cardiovascular risk factor variables. These results also persisted
when the sample was expanded to include individuals with a
history of hypertension-related comorbidity and other major
disease.
The majority of these inverse associations were higher in
magnitude for the African-American cohort than for the Caucasian-American cohort. These included relations of both SBP
and DBP to four of the WAIS test scores (Block Design, Digit
Symbol Substitution, Information, and Similarities), and the
Global Composite. The only WAIS tests for which associations with SBP and DBP did not differ between the racial
cohorts were the Digit Span tests. However, the magnitude of
inverse associations between pulse pressure values and cognitive functioning did not generally differ between the racial
cohorts, with one exception. For the African Americans, compared with the Caucasian Americans, pulse pressure exhibited
a higher magnitude of association with Digit Symbol Substitution scores.
The pattern of BP effects observed in our investigation is
consistent with the literature indicating that hypertension and
increments in BP are associated with poorer performance in
multiple cognitive domains. Cognitive domains for which
associations of BP and cognitive performance are consistently
observed and tend to be high in magnitude include abstract
reasoning, psychomotor, and visual organization abilities
(6,7,26,33).
The cognitive test for which the strongest and most consistent associations between BP measures and cognition were
obtained in this study was Digit Symbol Substitution, a measure of psychomotor speed (34,35). Inverse associations were
obtained for each BP measure and both racial groups. Results
very similar to those for Digit Symbol Substitution were
observed for the Similarities test, which places demands on
concept formation and abstract reasoning abilities (29,34).
Psychosomatic Medicine 67:707–714 (2005)

Inverse associations of SBP and DBP with Digit Symbol
Substitution and Similarities were higher in magnitude for
African Americans than for Caucasian Americans. This result
was also obtained for Block Design, a measure of visualorganizational abilities (34).
The WAIS tests showing significant relationships with BP
measures assess the cognitive domains that are most likely to
show disproportionate decrement in relation to vascular
cognitive impairment (36) and vascular dementia (37,38).
Vascular dementia is relatively more common for African
Americans than Caucasian Americans (11). Thus the pattern
of results is consistent with the view that these BP-related
decrements in cognitive function may be early signs of a
process which, in the absence of intervention, can gradually
progress to vascular-related cognitive impairment (39).
The major limitations of the present study are that the data
are cross-sectional and we employed relatively well-educated
individuals. The absence of BP by age interactions, and curvilinear associations of BP, in relation to cognitive performance may be attributable to the fact that this was, on average,
a relatively young and well educated sample.
Results of this study indicate that, as is true for Caucasian
Americans, for African Americans high BP is related to poorer
performance in multiple cognitive domains. Because there is a
higher prevalence and incidence of elevated BP among African Americans across the life span (9), further investigation of
potential effects of high BP on cognitive functioning among
African Americans should be conducted using prospective and
longitudinal designs. Cross-sectional designs may produce an
under estimation of the long-term effects of high BP on
cognitive functioning (33).
Aggressive efforts toward preventing, detecting, and controlling hypertension in the African-American population may
help preserve cardiovascular health and cognitive abilities
(40). Although much that is done in this regard applies to
everyone, regardless of race, further research on socioeconomic and psychosocial factors that might disproportionately
affect the cardiovascular health of African Americans (41– 45)
is warranted.
We wish to thank Gregory Dore and Dawn Norris for technical
assistance.
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